Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-27

Clinical Trial Update: Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's Diarrhoea [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Rifamycin SV-MMX tablets to ciprofloxacin for acute traveler’s diarrhea has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ciprofloxacin (Ciprofloxacin hydrochloride)
  • Rifamycin SV-MMX (rifamycin SV-MMX)

Snippet

Sponsor: Dr. Falk Pharma GmbH | Conditions: Traveler's Diarrhea | Phase 3 | Status: COMPLETED | Results posted: 2019-02-27